Optical Coherence Tomography of Airway and Pleural Disorders - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Optical Coherence Tomography of Airway and Pleural Disorders

This study is enrolling participants by invitation only.
Information provided by University of California, Irvine

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Optical Coherence Tomography of Airway and Pleural Disorders

Official Title ^†

Optical Coherence Tomography of Airway and Pleural Disorders

Brief Summary

Endobronchial disorders represent abnormal processes within the network of passages delivering air to the lung, including lung cancers. Pleural disorders involve the membrane that covers the lung and lines the inside of the chest walls.

Early detection of these disorders is essential to timely, accurate diagnosis and treatment of these conditions including cancer, inflammation and infections.

Detailed Description

Optical methods for obtaining images in airway passages for early detection of endobronchial lung and pleural cancer are needed. Optical coherence tomography (OCT) is a non-invasive or minimally invasive diagnostic technique that can provide information about tissue abnormalities.

OCT can produce images of abnormalities both at and below the surface of the airways without damaging the tissue surface This technique uses a harmless device to emit infrared (not visible) light that can produce images of the specimen under investigation without causing damage or alterations.

Study Phase

Study Type ^†

Observational

Study Design ^†

Case-Only, Prospective

Primary Outcome Measure ^†

Screening aid in identification of suspect tissue lesion. [ Time Frame: 30 MINUTES ] [ Designated as safety issue: No ]

Secondary Outcome Measure ^†

Condition ^†

Endobronchial Disorder

Intervention ^†

Device: OCT

MEDLINE PMIDs

Links

Recruitment Information Fields

Recruitment Status ^†

Enrolling by invitation

Enrollment ^†

150

Start Date ^†

July 2007

Completion Date

July 2012

Eligibility Criteria ^†

Inclusion Criteria:

adult 18 or older, male or female.
require bronchoscopic with possible biopsy procedures.

Exclusion Criteria:

age less than 18 years of age
NO bronchoscopic with possible biopsy procedures.

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Administrative Information Fields

NCT ID ^†

NCT00580892

Organization ID

P41-RR01192;NIH-LAMMP

Secondary IDs ^††

Phillip Morris #32598

Study Sponsor ^†

University of California, Irvine

Collaborators ^††

Pulmonary and Critical Care Medicine, UCI medical Center
Chao Family Comprehensive Cancer Center
Beckman Laser Institute Medical Clinic

Investigators ^†

Principal Investigator:

Matthew Brenner, M.D

Beckman Laser Institute

Information Provided By

University of California, Irvine

Verification Date

March 2008

First Received Date ^†

December 20, 2007

Last Updated Date

March 26, 2008

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.